Literature DB >> 19504615

Efficacy of oral tacrolimus on intestinal Behcet's disease.

Kayoko Matsumura, Hiroshi Nakase, Tsutomu Chiba.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19504615     DOI: 10.1002/ibd.20970

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  13 in total

Review 1.  Gastrointestinal Behçet's disease: a review.

Authors:  Wasseem Skef; Matthew J Hamilton; Thurayya Arayssi
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 2.  Behçet's disease with intestinal involvement: case-based review.

Authors:  Marta B Dzhus; Tetiana A Karasevska; Vira M Tsaralunga; Alla V Yurchenko; Olexiy I Ivashkivsky
Journal:  Rheumatol Int       Date:  2022-06-04       Impact factor: 3.580

Review 3.  A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.

Authors:  Shojiro Watanabe; Tomomi Aizawa-Yashiro; Kazushi Tsuruga; Manabu Kinjo; Etsuro Ito; Hiroshi Tanaka
Journal:  Rheumatol Int       Date:  2012-12-25       Impact factor: 2.631

4.  Development of Immunopathogenesis Strategies to Treat Behçet's Disease.

Authors:  Osman Köse
Journal:  Patholog Res Int       Date:  2012-04-03

Review 5.  Updated treatment strategies for intestinal Behçet's disease.

Authors:  Yong Eun Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2017-12-08       Impact factor: 2.884

6.  Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yukinori Nakamura; Masafumi Matsuguma; Yoshihiro Tokunaga; Kaoru Yamamoto; Mayumi Tanaka; Yoshinori Tanaka; Toshiaki Yujiri; Yukio Tanizawa
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

Review 7.  Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases.

Authors:  Carmen Rodriguez-Cerdeira; Elena Sanchez-Blanco; Alberto Molares-Vila
Journal:  Mediators Inflamm       Date:  2012-11-01       Impact factor: 4.711

Review 8.  Diagnosis and management of intestinal Behçet's disease.

Authors:  Tadakazu Hisamatsu; Makoto Naganuma; Katsuyoshi Matsuoka; Takanori Kanai
Journal:  Clin J Gastroenterol       Date:  2014-04-20

9.  Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.

Authors:  Mariko Kaji; Takayuki Kishi; Takako Miyamae; Satoru Nagata; Hisashi Yamanaka; Satoshi Fujikawa
Journal:  Case Rep Rheumatol       Date:  2015-11-02

Review 10.  Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease.

Authors:  Tadakazu Hisamatsu; Mari Hayashida
Journal:  Intest Res       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.